Diabetes Quality of Life Measure
Also known as: DQOL, Diabetes Quality of Life, Diabetes QOL
The DQOL is a patient-reported measure of quality of life impact in people with diabetes. Developed by the Diabetes Control and Complications Trial (DCCT) Research Group in 1988, this 46-item questionnaire assesses how diabetes affects daily functioning, emotional well-being, worry about complications, and satisfaction with life and health. It is widely used in diabetes clinical trials and research to capture the burden of diabetes management and impact on psychosocial well-being.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The DQOL is indicated for comprehensive quality-of-life assessment in diabetes populations. Use cases include baseline assessment of psychological burden and satisfaction to inform patient-centered interventions, evaluating new diabetes treatments (medications, devices, educational programs) as a secondary outcome alongside glycemic control, monitoring psychological outcomes in clinical practice to detect distress or burnout requiring intervention, research examining long-term consequences of diabetes and its management, and health economic analyses. The DQOL is particularly valuable in type 1 diabetes trials and in studies examining intensive glycemic control or novel insulin regimens. It is less suitable for very young children or for non-diabetes populations.
Strengths & limitations
- Comprehensive coverage of diabetes-specific burden—addresses satisfaction with treatment, daily-life impact, worry about hypoglycemia and long-term complications, and social/vocational concern, capturing the multifaceted experience of living with diabetes
- Extensively validated—used in the landmark DCCT trial and hundreds of subsequent studies, demonstrating solid psychometric properties (Cronbach's α 0.60-0.85 across subscales) and responsiveness to treatment and interventions
- Developed in major clinical trial—created and refined within the DCCT, a rigorous, multi-center trial, ensuring instrument validity and clinical relevance
- Addresses psychological burden specifically—captures distress and worry relevant to diabetes that generic QoL measures miss
- Free and widely accessible—available for research and clinical use without licensing restrictions, with published scoring algorithms
- Modest internal consistency on some subscales—some domains (e.g., Social/Vocational Worry with only 3 items) have lower Cronbach's α (<0.70), affecting reliability for individual subscale scores; use overall DQOL cautiously
- Limited responsiveness on satisfaction subscale—satisfaction scores may be relatively stable even after interventions, whereas Impact and Worry scales show greater sensitivity to change
- Does not assess glycemic control or clinical outcomes—measures quality of life separate from HbA1c; both must be assessed independently to evaluate diabetes management success
- Age considerations—developed for adults; use and validity in adolescents and children require separate validation
- Potential sociodemographic bias—response patterns vary by age, education, socioeconomic status, and type of diabetes; comparison to disease-specific norms is important for contextual interpretation
Frequently asked
Should DQOL guide treatment intensification decisions?
DQOL is one input among many. A patient with HbA1c 8.5% and high DQOL Impact/Worry scores may benefit from treatment simplification or intensification depending on context: type 1 diabetes with unavoidable insulin dependency suggests intensive diabetes education and psychological support; type 2 diabetes might benefit from adding a simpler agent (once-daily GLP-1, SGLT2i) to reduce burden. Always balance DQOL with glycemic targets, comorbidities, and patient preferences.
How do I interpret low Satisfaction subscale scores?
Low Satisfaction (high dissatisfaction) indicates the patient is unhappy with current treatment regimen—complexity, side effects, or perception of effectiveness. Explore reasons: Is the regimen too burdensome? Are side effects present? Does the patient doubt benefit? Consider regimen simplification, education, or shared decision-making about alternatives. However, do not change therapy solely to improve Satisfaction at the expense of glycemic control.
Is DQOL appropriate in type 2 diabetes?
DQOL was developed in type 1 diabetes but has been validated in type 2 populations. Interpretation differs: type 2 patients often report lower overall burden (oral therapy vs. insulin injection), but those on insulin or multiple daily injections may report comparable Impact and Worry. Use disease-specific reference values; separate normative data for type 1 and type 2 exist in literature.
How does DQOL relate to HbA1c improvement during treatment?
DQOL and HbA1c are often independent. A patient achieving HbA1c reduction from 10% to 7% may show no DQOL improvement if the intensified regimen is burdensome, or may show improvement if the simpler regimen (e.g., once-daily therapy) is easier. Use both measures: HbA1c reflects glucose control; DQOL reflects perceived burden and well-being. Optimal treatment achieves both.
Sources
- The Diabetes Control and Complications Trial Research Group. (1988). The Diabetes Quality of Life (DQOL) measure. Diabetes Care, 11(10), 725-732. link ↗
- Jacobson, A. M., de Groot, M., & Samson, J. A. (1994). The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care, 17(4), 267-274. DOI: 10.2337/diacare.17.4.267 ↗
- Bott, U., Hendrieckx, C., Mohr-Riehle, B., & Nagaraja, H. N. (2016). Psychosocial outcomes of therapy with real-time continuous glucose monitoring systems. Diabetes Technology & Therapeutics, 18(5), 314-322. link ↗
How to cite this page
ScholarGate. (2026, June 3). Diabetes Quality of Life Measure. ScholarGate. https://scholargate.app/en/health-outcomes/diabetes-quality-of-life
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- ACTHealth Outcomes↔ compare
- CATHealth Outcomes↔ compare
- CHQHealth Outcomes↔ compare
- EORTC QLQ-C30Health Outcomes↔ compare